2017 Biomedical Informatics Symposium at Georgetown October 27, 2017
The 6th annual Biomedical Informatics symposium at Georgetown was a huge success with over 270 registered participants and a poster session that included over 35 selected scientific, team science projects from across the Georgetown community, affiliated local universities, industry sponsors, and other collaborators. Many leaders in the field of bioinformatics joined us to share their work in important areas of Precision Medicine, Big Data in Biomedicine, and Emerging Technologies for Health Data Analytics.Deloitte andGenomOncology sponsored a lunch panel that discussed Decision Support for Precision Oncology and Health Registries as a means to Advance Therapeutic Development below is a summary of talks and panel discussions.
The event was graciously supported by many industry partners listed below:
In addition we had institutional support from our Lombardi Comprehensive Cancer Center, the Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS), and the Georgetown Center of Excellence in Regulatory Science and Innovation (CERSI).
The program booklet with talk titles as well as poster abstracts can be found here (new window) For more information about the day please read the #GUInformatics tweets (new window)and a new blog post by Subha Madhavan, Chair, Symposium Program Committee.
Presentations from the 2017 symposium
Patricia Brennan, RN, PhD, Director of the National Library of Medicine
We were delighted to welcome Dr. Patricia Brennan as the Keynote Speaker for the 2017 ICBI Symposium.
Keynote Address: The future of Data-powered Health
Panel 1: Distributed, Large Cancer Networks Driving Precision Oncology
Chair: John Marshall, MD, MedStar Georgetown University Hospital
Zach Weinberg, Flatiron
Building a Real-World Clinico-Genomic Database
Robert Currie, MBA, University of California Santa Cruz
The Cancer Gene Trust: Towards a World Wide Genomic Internet
Hongyue Dai, PhD, M2Gen
Robert S. Miller, MD, FACP, FASCO, ASCO
ASCO’s CancerLinQ: Real-World Insights to Drive Quality Improvement and Precision Oncology
Danielle Carnival, PhD, Biden Foundation
Cancer Moonshot and Beyond: National Initiatives to Advance Health
Panel 2: Are we Educating the Next Generation of Data Scientists to Take on Emerging Challenges?
Yuriy Gusev, PhD, Georgetown University
Of MOOCs, Flying Cars and Nano-Degrees.
Ben Busby, PhD, National Institute of Health
Hackathons, Visitor Sprints and Student Competitions: Adventures in Unconventional Data Science Training!
Francois Modave, PhD, University of Florida
Data Science, Core Competencies, and Program Accreditation.
Baris Suzek, PhD, Georgetown University
An International Perspective on Bioinformatics Education; Challenges & Solutions
Panel 3: Informatics Tools for Cancer Surveillance
Chair: Christopher Loffredo, PhD, Georgetown University
Valentina Petkov, MD, MPH, National Institute of Health
National Cancer Institute’s SEER Program in the 21st century
Eric Durbin, PhD, University of Kentucky
The Kentucky Cancer Registry: Our Journey Towards Precision Cancer Surveillance
Antoinette Stroup, PhD, Rutgers University.
New Jersey State Cancer Registry: Fighting Cancer with Quality Data and Innovative Research
Panel 4: Current Trends in Molecular Diagnostics
Chair: Robert Beckman, MD, Georgetown University
Sharon Plon, MD, PhD, Baylor University
Advances in Cancer Molecular Diagnostics for Pediatric Cancer Patients
Robert B. Scharpf, PhD, Johns Hopkins University
Integrated Genomic Analyses of Ovarian Cancer Cell Lines
Pamela Becker, MD, PhD, University of Washington
Implementing Precision Medicine Clinical Trials for Refractory Acute Leukemia Based on Molecular Data and Functional Screening
Panel 5: Will Artificial Intelligence and Machine Learning Deliver for Biomedicine? How soon?
Chair: Jason Moore, PhD, University of Pennsylvania
Automated Machine Learning
David Page, PhD, University of Wisconsin at Madison
High Throughput Machine Learning for Health Care
Yue Joseph Wang, PhD, Virginia Tech
Machine Learning for Improved Relevance of Pathways and Markers
Manuel Glynias, BA, GenomeOncology
Decision Support for Precision Oncology
Juergen Klenk, PhD, and Kimberly Myers, PhD, Deloitte
Health Registries as a Means to Advance Therapeutic Development